Evidence map›Paper›PMID 20554220›Full record

ReviewCytokine2010

Cytokine dependent and independent iNKT cell activation.

Emma C Reilly, Jack R Wands, Laurent Brossay

Abstract readReview
In one paragraph

Review in Cytokine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Invariant natural killer T cells in lung diseases.Experimental & molecular medicine · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. The iNKT Cell-Macrophage Axis in Homeostasis and Disease.International journal of molecular sciences · 2022
    Review
  11. Review
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emma C ReillyDepartment of Molecular Microbiology and Immunology and Graduate Program in Molecular Biology, Cell Biology and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA.
Jack R Wands
Laurent Brossay
Brown University · US

Funding

NK T Cell Interactions with NK Cells During Viral InfectionR01AI046709 · NIAID · BROWN UNIVERSITY · PI BROSSAY, LAURENT · 2001 to 2022
$8.0M
STUDY OF HBV AND/OR VARIANTS IN ALCOHOLICSR01AA008169 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 1989 to 2011
$3.9M
Research Training Program in GastroenterologyT32DK060415 · NIDDK · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 2003 to 2013
$1.5M
NK RECEPTORS AND CD1 ROLES IN NK AND NK T CELL FUNCTIONR21AI046709 · NIAID · BROWN UNIVERSITY · PI BROSSAY, LAURENT · 2000 to 2000
$233k
NIAAA NIH HHS AA-08169NIAAA NIH HHS R01 AA008169NIAID NIH HHS AI46709NIAID NIH HHS R01 AI046709NIAID NIH HHS R21 AI046709NIDDK NIH HHS T32 DK060415NIDDK NIH HHS T32 DK60415-05
6 · The paper itself

Abstract

Invariant NKT (iNKT) cells have been extensively studied throughout the last decade due to their ability to polarize and amplify the downstream immune response. Only recently however, have the various mechanisms underlying NKT cell activation begun to unfold. iNKT cells have the ability to respond as innate immune cells with minimal TCR involvement as well as through direct TCR recognition of glycolipid antigens. Additionally, the existence of several subsets of iNKT cells creates the potential for other unique pathways, which are not yet clearly defined. Here, we provide an overview of the known mechanisms of invariant NKT cell activation, focusing on cytokine driven pathways and the resulting cytokine responses.

Indexed as

AnimalsCytokinesHumansLymphocyte ActivationNatural Killer T-CellsReceptors, Antigen, T-CellReceptors, Natural Killer CellToll-Like ReceptorsCytokinesReceptors, Antigen, T-CellReceptors, Natural Killer CellToll-Like Receptors

Identifiers

PMID20554220
PMCPMC2914806
OpenAlexW2070918736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.